Contemporary insights into the pathogenesis and treatment of chronic myeloproliferative neoplasms Journal Article


Authors: Mughal, T. I.; Abdel-Wahab, O.; Rampal, R.; Mesa, R.; Koschmieder, S.; Levine, R.; Hehlmann, R.; Saglio, G.; Barbui, T.; Van Etten, R. A.
Article Title: Contemporary insights into the pathogenesis and treatment of chronic myeloproliferative neoplasms
Abstract: This review is based on the deliberations at the 5th John Goldman Colloquium held in Estoril on 2nd October 2015 and the 9th post-ASH International Workshop on chronic myeloid leukemia (CML) and BCR-ABL1-negative myeloproliferative neoplasms (MPN) which took place on the 10th–11th December 2014, immediately following the 56th American Society of Hematology Annual Meeting. It has been updated since and summarizes the most recent advances in the biology and therapy of these diseases, in particular updates of genetics of MPN, novel insights from mouse MPN models, targeting CML stem cells and its niche; clinical advances include updates on JAK2 inhibitors and other therapeutic approaches to BCR-ABL1-negative MPNs, the use of alpha interferons, updates on tyrosine kinase inhibitors (TKI) randomized trials in CML, TKI cessation studies, and optimal monitoring strategies. © 2016 Informa UK Limited, trading as Taylor & Francis Group.
Keywords: molecular genetics; myeloid leukemias and dysplasias; stem and primitive progenitor cells
Journal Title: Leukemia and Lymphoma
Volume: 57
Issue: 7
ISSN: 1042-8194
Publisher: Taylor & Francis Group  
Date Published: 2016-01-01
Start Page: 1517
End Page: 1526
Language: English
DOI: 10.1080/10428194.2016.1185783
PROVIDER: scopus
PUBMED: 27240645
PMCID: PMC6077976
DOI/URL:
Notes: Review -- Export Date: 1 July 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Raajit Kumar Rampal
    339 Rampal
  2. Ross Levine
    778 Levine